Beranda › Gagal Ginjal › Pennsylvania
Uji klinis Gagal Ginjal di Pennsylvania
7 studi untuk Gagal Ginjal mencari peserta di lokasi di Pennsylvania.
Kota di Pennsylvania
Teks studi resmi (Bahasa Inggris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Northeast Clinical Research Center, LLC, Bethlehem
- Clinical Renal Associates, LTD, Exton
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Research Site, Bethlehem
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06749457Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- Butler Memorial Hospital, Butler
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT04634916Virtual Reality in End Stage Kidney Disease
- University of Pennsylvania, Philadelphia
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06356168PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
- University Pittsburgh Medical Center, Pittsburgh
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT06422871Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
- Perelman Center for Advanced Medicine, Philadelphia
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07446296A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Guthrie Clinic, Sayre
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 22 Des 2025 · NCT04671771Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.